This inventor holds 4 USPTO granted patents. Top assignees: Mundipharma Ag, Synergistics, Inc., The Purdue Frederick Company. Active years: 1976-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- LATE OF Liverpool, EN (1976 - 1977)
- LATE OF Liverpool, GB (1978 - 1979)
Company Filing History:
2 out of 2 
1 out of 4 
1 out of 27 Years Active: 1976-1979
Title: William Kelly, Deceased: A Legacy of Innovation in Pharmaceutical Chemistry
Introduction
William Kelly was a notable inventor in the field of pharmaceutical chemistry. He is remembered for his contributions to the development of stabilized choline salicylate compounds. His work has had a lasting impact on the formulation of pharmaceutical preparations.
Latest Patents
William Kelly held a total of 4 patents during his career. His latest patents include innovations related to stabilized choline salicylate compounds. These compounds, specifically choline salicylate sulfite and choline salicylate alkali metal sulfite-containing compounds, are designed to inhibit color formation in pharmaceutical preparations. The methods for their preparation and use are also disclosed in his patents, showcasing his commitment to improving pharmaceutical formulations.
Career Highlights
Throughout his career, William Kelly worked with prominent companies in the pharmaceutical industry. He was associated with Mundipharma AG and The Purdue Frederick Company. His work in these organizations allowed him to contribute significantly to the field of pharmaceutical chemistry.
Collaborations
William Kelly collaborated with notable individuals such as Alfred Halpern and Monica Kelly, who served as a representative. These collaborations enriched his work and helped advance his innovative ideas.
Conclusion
William Kelly's contributions to pharmaceutical chemistry through his patents and collaborations have left a significant mark on the industry. His legacy continues to influence the development of stable pharmaceutical formulations today.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile